Maitreya Medicare Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 824,000 (45%) | — | ₹676 Cr |
| NII (HNI) | — | 272,000 (15%) | — | ₹223 Cr |
| Retail | — | 611,200 (34%) | — | ₹501 Cr |
| Market Maker | — | 108,800 (6%) | — | ₹9 Cr |
| Σ Total | — | 1,816,000 (100%) | — | ₹14,891 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹131,200 |
| Retail (Max) | 13 | 20,800 | ₹1,705,600 |
| S-HNI (Min) | 14 | 22,400 | ₹1,836,800 |
| B-HNI (Min) | 67 | 107,200 | ₹8,790,400 |
Financial Statements Amount in ₹ Lakhs
| Metric | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Revenue | 2,485 | 3,995 | 2,449 |
| Profit After Tax | 254 | 423 | 114 |
| Net Worth | 1,118 | 864 | 471 |
| Total Assets | 3,122 | 2,750 | 2,449 |
| Total Borrowing | 520 | 585 | 750 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Making investment through Equity in the subsidiary named ‘Maitreya Hospital Private Limited’ for setting up Hospital at Valsad, Gujarat – 7.50
- Redemption of part of issued Non-Convertible Redeemable Preference Shares – 1.00
- Funding the working capital requirements of the company – 5.00
- General Corporate Purposes – 0.74
Company Overview
Incorporated in 2019, Maitreya Medicare Limited is a multispeciality hospital situated in Surat, Gujrat. The main focus of the hospital is multi-disciplinary integrated healthcare services, with primary secondary & tertiary care. Maitreya Medicare offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Laparoscopic Surgery, Oncology, Neurosurgery, Spine Surgery, Neurology, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine, etc.
As of 2023, the hospital has a 125-bed capacity under the leadership of Dr. Narendra Singh Tanwar, founder, Promoter, CFO, and Managing Director of the hospital, Dr Pranav Rohitbhai Thaker, Promoter & whole-time director, and Mr. Vimal Patel, Promoter & Whole Time Director.